Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Filed with BSE · · 4 pages · English
Goldline Pharmaceutical Ltd. on 6ix
Earlier from Goldline Pharmaceutical
- Goldline Pharmaceutical Ltd. Press Release Jun 09 2026
- Announcement under Regulation 30 (LODR)-Change in Management
- Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
- Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
- Goldline Pharmaceutical Ltd. Press Release Jun 02 2026
Later from Goldline Pharmaceutical
- Goldline Pharmaceutical Ltd. Press Release Jun 24 2026
- Goldline Pharmaceutical Ltd. Press Release Jul 14 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Goldline Pharmaceutical Ltd. Press Release Jul 20 2026
- Goldline Pharmaceutical Ltd. Press Release Jul 30 2026
Follow Goldline Pharmaceutical into a list and get an email when it puts out news.
Follow Goldline Pharmaceutical